Skip to main content
. 2018 Apr 26;23(9):1008–1015. doi: 10.1634/theoncologist.2017-0629

Figure 2.

image

The targeted genetic profiles of younger and older patients with lung adenocarcinoma. (A): The targeted genetic profile of the younger patients, aged less than 45 years. (B): The targeted genetic profile of the older patients, aged more than 45 years. (C): The comparative analysis of the frequency of targeted genetic alterations between the younger and the older group. Statistical significance was defined as p < .05.

Abbreviations: amp, amplification; mut, mutation.